Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002804480 | SCV003597959 | uncertain significance | Inborn genetic diseases | 2022-01-05 | criteria provided, single submitter | clinical testing | The c.1096T>C (p.F366L) alteration is located in exon 8 (coding exon 8) of the CNTNAP2 gene. This alteration results from a T to C substitution at nucleotide position 1096, causing the phenylalanine (F) at amino acid position 366 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003143547 | SCV003831103 | uncertain significance | Cortical dysplasia-focal epilepsy syndrome | 2022-07-27 | criteria provided, single submitter | clinical testing |